Functional Microbiomics Core
Functional Microbiomics Core
批准号:
10492098
负责人:
HARIBABU BODDULURI
金额:
$75.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
未结题
起止时间:
2018-03-01 至 2028-02-29
关键词:
3xTg-AD mouseAdministrative SupplementAdoptedAgingAlzheimer&aposs DiseaseAreaAwardBehaviorBioinformaticsBiologicalBlood - brain barrier anatomyBreedingCenters of Research ExcellenceCore FacilityData AnalysesDedicationsDerivation procedureDevelopmentEdible PlantsEquipmentExtramural ActivitiesFee-for-Service PlansFosteringFundingFutureGenomicsGerm-FreeGnotobioticGoalsHistopathologyHousingImageIndividualInflammationInflammation MediatorsInfrastructureInstitutionJointsKnockout MiceLaboratoriesMentorsMethodologyMissionModelingMusNational Institute of General Medical SciencesPathogenesisPathogenicityPhasePlayProcessProtocols documentationResearchResearch PersonnelResearch Project GrantsResearch SupportResourcesRibosomal DNARoleSamplingServicesSystemTechniquesTestingTissuesTrainingTraining and EducationTransgenic OrganismsTranslational ResearchUniversitiesWhole OrganismWorkanimal facilitycancer immunotherapyclinical translationexosomeexperimental studyimaging facilitiesin vivo imaging systeminnovationintravital microscopymetabolomicsmicrobiome researchmicrobiotamicroscopic imagingmorris water mazemouse modelmulti-photonnanoporenovelobject recognitionprogramsprotocol developmentsuccesssynthetic polymer Bioplextooltumor immunology
中文摘要
项目总结/文摘
英文摘要
Project Summary/Abstract
In this Phase 2 of the Functional Microbiomics, Inflammation and Pathogenicity COBRE, the primary goal of the
Functional Microbiomics Core (FMC) is unchanged. We will sustain and enhance the well-established integrated
service center that functions as a critical resource for the Research Project Leaders (RPLs) as a priority, and
secondarily for all investigators of the Center. Since all new COBRE projects also utilize mouse models to explore
the inter-relationships between inflammation and pathogenesis, and the contribution of microbiota to this
process, our well-established germ-free and gnotobiotic mice facility (GMF) will continue to play a central role in
services provided by the FMC. We will continue to provide anaerobic culturing of mixed and/or mono bacterial
strains to facilitate the specific colonization of the germ-free mice. 16S ribosomal DNA will be profiled with the
in-house developed Oxford nanopore sequencing as well as PacBio-long read sequencing tools, and
bioinformatic support provided. Our most extensively used resource; multiplex-based analysis of inflammatory
mediators in biological samples, will continue to function using the Bio-Plex 200 (Bio-Rad) multiplex system. In
addition, several recent advances allow us to augment the services provided by the FMC. First, the recently
developed, highly successful rederivation service of transgenic and KO mouse models as germ-free, will greatly
expand the scope and utility of the GMF. Related to this service is the development of a new area of research
on the role of microbiota in Alzheimer’s Disease (AD) supported by an administrative supplement to the FMC
from NIA/NIGMS. The GMF has already rederived several AD mouse models. For this project, the FMC also
developed a suite of mouse behavior analysis models including the Morris Water Maze and Novel Object
Recognition tests. These services will support all future ageing related research at the center including a new
project on the role of edible-plant derived exosomes in restoring the integrity of the Blood Brain Barrier. We also
now include imaging support, in particular Multiphoton Intravital Microscopy for imaging of live tissue and an In
Vivo Imaging System (IVIS) for live mouse imaging. Besides functioning as a service center, another major goal
of the FMC is to promote the education and training of researchers, primarily the RPLs. The FMC will also interact
with other Core facilities at the University of Louisville, such as the Genomics, Metabolomics and Bioinformatics
core facilities established with the support of other highly successful COBRE/INBRE programs. In particular, the
newly funded Cancer Immunology and Immunotherapy COBRE-operated Functional Immunomics Core (FIC)
facility also directed by Dr. Bodduluri has several joint initiatives with the FMC including the establishment of a
histopathology service center. The FMC will work with these and other UofL resources in order to avoid
duplication of equipment, and to train individual investigators in specific protocols, foster innovative protocol
development and integrate analysis of data.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Functional Microbiomics Core-Bodduluri
-
批准号:10349568
-
项目类别:
-
资助金额:$54.71万
-
财政年份:2018
-
负责人:HARIBABU BODDULURI
-
依托单位:
Role of leukotriene B4 receptors in the interplay of inflammation and infection
-
批准号:8433515
-
项目类别:
-
资助金额:$27.87万
-
财政年份:2009
-
负责人:HARIBABU BODDULURI
-
依托单位:
Role of leukotriene B4 receptors in the interplay of inflammation and infection
-
批准号:8210894
-
项目类别:
-
资助金额:$29.66万
-
财政年份:2009
-
负责人:HARIBABU BODDULURI
-
依托单位:
Role of leukotriene B4 receptors in the interplay of inflammation and infection
-
批准号:8015283
-
项目类别:
-
资助金额:$29.67万
-
财政年份:2009
-
负责人:HARIBABU BODDULURI
-
依托单位:
Role of leukotriene B4 receptors in the interplay of inflammation and infection
-
批准号:7635082
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2009
-
负责人:HARIBABU BODDULURI
-
依托单位:
Leukotriene B4 Receptors in Rheumatoid Arthritis
-
批准号:7032234
-
项目类别:
-
资助金额:$28.71万
-
财政年份:2003
-
负责人:HARIBABU BODDULURI
-
依托单位:
Leukotriene B4 Receptors in Rheumatoid Arthritis
-
批准号:6706978
-
项目类别:
-
资助金额:$29.33万
-
财政年份:2003
-
负责人:HARIBABU BODDULURI
-
依托单位:
Leukotriene B4 Receptors in Rheumatoid Arthritis
-
批准号:6610703
-
项目类别:
-
资助金额:$27.01万
-
财政年份:2003
-
负责人:HARIBABU BODDULURI
-
依托单位:
Leukotriene B4 Receptors in Rheumatoid Arthritis
-
批准号:6858582
-
项目类别:
-
资助金额:$29.4万
-
财政年份:2003
-
负责人:HARIBABU BODDULURI
-
依托单位:
REGULATION OF HIV-1 CORECEPTORS
-
批准号:6019921
-
项目类别:
-
资助金额:$4.03万
-
财政年份:2000
-
负责人:HARIBABU BODDULURI
-
依托单位:
REGULATION OF HIV-1 CORECEPTORS
-
批准号:6343929
-
项目类别:
-
资助金额:$3.96万
-
财政年份:2000
-
负责人:HARIBABU BODDULURI
-
依托单位:
REGULATION OF HIV-1 CORECEPTORS
-
批准号:6490990
-
项目类别:
-
资助金额:$3.96万
-
财政年份:2000
-
负责人:HARIBABU BODDULURI
-
依托单位:
REGULATION OF HIV1 CORECEPTORS CXCR4
-
批准号:6430448
-
项目类别:
-
资助金额:$3.74万
-
财政年份:1998
-
负责人:HARIBABU BODDULURI
-
依托单位:
REGULATION OF HIV1 CORECEPTORS CXCR4
-
批准号:6373841
-
项目类别:
-
资助金额:$15.37万
-
财政年份:1998
-
负责人:HARIBABU BODDULURI
-
依托单位:
REGULATION OF HIV1 CORECEPTORS CXCR4
-
批准号:2887741
-
项目类别:
-
资助金额:$11.0万
-
财政年份:1998
-
负责人:HARIBABU BODDULURI
-
依托单位:
REGULATION OF HIV1 CORECEPTORS CXCR4
-
批准号:2649238
-
项目类别:
-
资助金额:$11.48万
-
财政年份:1998
-
负责人:HARIBABU BODDULURI
-
依托单位:
REGULATION OF HIV1 CORECEPTORS CXCR4
-
批准号:6170745
-
项目类别:
-
资助金额:$6.82万
-
财政年份:1998
-
负责人:HARIBABU BODDULURI
-
依托单位:
REGULATION OF HIV1 CORECEPTORS CXCR4
-
批准号:6510839
-
项目类别:
-
资助金额:$9.36万
-
财政年份:1998
-
负责人:HARIBABU BODDULURI
-
依托单位:
海外基金